Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia With Daridorexant in Canada - Trial NCT06311864
Access comprehensive clinical trial information for NCT06311864 through Pure Global AI's free database. This phase not specified trial is sponsored by PeriPharm and is currently Not yet recruiting. The study focuses on Insomnia. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
PeriPharm
Timeline & Enrollment
N/A
May 20, 2024
Nov 01, 2024
Primary Outcome
Change from Baseline in Quality of Life,Change from Baseline in Work Productivity Loss,Change from Baseline in the Severity of Insomnia Symptoms
Summary
The purpose of this observational study is to evaluate the impact of daridorexant on quality
 of life, work productivity and insomnia symptoms in Canadian adults suffering from insomnia.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06311864
Non-Device Trial